Tricalcium phosphate doped with a small amount of both V(III) and V(V) ions (V-β-TCPV) was successfully prepared using a solid-state reaction, and its in vitro cell cytotoxicity was investigated using V79 cells. We found that the V(III) ion was substituted for a Ca ion at the Ca(5) site located in the β-Ca 3 (PO 4 ) 2 (β-TCP) crystal structure and that the V(V) ion was substituted for a P ion in the PO 4 group of the β-TCP crystal structure. The cell cytotoxicity of the V-β-TCPVs increased gradually with increasing amounts of vanadium ion doping. The β-TCP doped with 1.0 mol% vanadium ions showed low toxicity. V-β-TCPVs doped with a small amount of vanadium ions are expected to be significant new implant biomaterials.
INTRODUCTION
Beta-Tricalcium phosphate (β-TCP) has been used as a bone and tooth implant material because of its excellent biocompatibility, osteoinductivity, bioresorbability, and safety in living tissues. 1, 2 It has been reported previously that monovalent (Li, Na, and K), divalent (Mg), and trivalent (Al) metal ions can be easily substituted for Ca 2+ ions in a β-TCP structure, which enhances its mechanical characteristics, improves its thermal stability toward the β-α phase transition of TCP, and controls its solubility. 3, 4 The cellular evaluation of β-TCP doped with vanadium (III) ion (V-β-TCP) has been examined using mouse MC3T3-E1 osteoblast-like cells and V-β-TCP with 2-3 mol% promoted proliferation and differentiation of osteoblasts. 5 Furthermore, the sinterability and good mechanical characteristics of β-TCP doped with vanadium (V) ion (β-TCPV) have also been demonstrated. 6 However, it is known that vanadium ions can be cytotoxic. 7 In this study, a solid-state reaction was carried out to prepare β-TCP doped with a small amount of both V(III) and V(V) ions, and its in vitro cell cytotoxicity was investigated using V79 cells.
MATERIALS AND METHODS
β-TCP powders doped with vanadium ions (V-β-TCPV) were synthesized using a solid-state reaction. The stoichiometric composition of β-TCP was considered to be Ca 21 □(PO 4 ) 14 , where □ denotes vacancies (cation sites: 4.55 mol%). The (Ca + V + □)/(P + V) molar ratio was constant at 1.5714, and the amount of vanadium added is indicated in Table 1 . CaHPO 4 ·2H 2 O (Kishida Chemical, Japan), CaCO 3 (Kishida Chemical, Japan), and NH 4 VO 3 (Kishida Chemical, Japan) were used as starting materials. V(III) ions were substituted in the Ca(5) sites (3Ca + □ Ca(4) = 2V 3+ + 2□ Ca(4) ), while V(V) ions were substituted in the P sites in the β-TCP crystal structure. The electric charge of the V 3+ and Ca 2+ ions was compensated with vacancies. The starting materials were mixed using Al 2 O 3 ball milling. The mixtures were heated at 1000°C for 12 h in air. After the obtained powders were crushed, the crystalline phases were investigated using an X-ray powder diffractometer (XRD) with a rotating anode X-ray tube (RINT-1500, Rigaku, Tokyo, Japan). The lattice constants for the rhombohedral unit cell in the hexagonal setting were also determined using an XRD. They were refined by the least-squares method using silicon powder as an external standard and using a software (RINT/DMAX-2000 Ver. 4.000, Rigaku); the reflection planes (1 1 1), (2 2 0), (3 1 1), and (4 0 0) of silicon and (2 0 10), (2 1 8), (2 2 0), (3 2 8) , and (2 0 20) of β-TCP were used to calculate the lattice constants. The ionic states of vanadium in the β-TCP structure were investigated by the diffuse reflectance method using KBr (Kishida Chemical) and with a Fourier transform infrared spectroscopy (FT-IR) spectrophotometer (FT/IR-230, JASCO, Tokyo, Japan).
Cytotoxicity tests are essential before new biomaterials are evaluated in vivo. Therefore, cytotoxicity tests were performed for V-β-TCPVs containing 0-1.5 mol% of vanadium using an extraction method (colony assay) according to ISO 10993-5 (Biological Evaluation of Medical Devices-Part 5: Tests for in Vitro Cytotoxicity). 8 First, Chinese hamster lung fibroblasts (V79 cells) were obtained from Health Science Research Resources Bank (Japan Health Sciences Foundation), cultured in Eagle's minimal essential medium (Eagle's MEM, Nissui Pharmaceutical Co. Ltd.) supplemented with 10 vol% fetal bovine serum (FBS, Life Technologies, Auckland, New Zealand), and placed in a CO2 incubator (37°C, 5% CO2 atmosphere).
However, Eagle's MEM containing 5 vol% FBS and 1 mmol cm -3 sodium pyruvate (M05 medium) was used to perform the cytotoxicity tests. In these tests, 0.1 g cm -3 of previously autoclave-sterilized V-β-TCPVs powder was added to the M05 medium. The sample was incubated in a CO2 incubator (37°C, 5% CO2 atmosphere) for 24 h, and then the medium was decanted to obtain the extract (100% extract). The extract was diluted with the M05 medium in order to prepare test solutions with concentrations ranging from 2.0 to 100%. V79 cells were seeded at 100 cells cm -3 in 2.0 cm 3 of M05 medium on a six-well (35 mm) culture dish. After the medium was incubated for 24 h, it was exchanged for either 2.0 cm 3 of diluted test solution or fresh M05 medium (control). After 6 days of the second culturing, the solution was discarded, and the cells were fixed with methanol and stained by 10 vol% Giemsa staining solution. Then, the colonies in each well were counted using a pixel catcher and an analyzer (PCA-11D, System Science Co. Ltd., Tokyo, Japan). The cytotoxicity potential is expressed as the mean percentage ± SD of the number of colonies formed with respect to that of the control (M05 medium without test solution) or as the index of cytotoxicity, defined as the concentration of the extract that suppressed the formation of cell colonies by 50% in comparison with the control (50% lethal concentration, IC50). High-density polyethylene film was used as the negative control, while polyurethane films containing 0.1% zinc diethyldithiocarbamate (ZDEC) or 0.25% zinc dibutyldithiocarbamate (ZDBC) were used as positive controls. The cytotoxicities of these films were evaluated using the same methods described above. shows the X-ray diffraction patterns of V-β-TCPVs doped with 0-1.5 mol% vanadium ions. All samples had diffraction patterns indicative of β-TCP structure. When vanadium ions were substituted for Ca 2+ and P ions in β-TCP, the diffraction patterns did not shift remarkable. FIGURE 2 shows the lattice parameters of the samples. In this figure, trivalent vanadium is substituted in a Ca site in V-β-TCP and pentavalent vanadium is substituted in a P site in β-TCPV 6 . The lattice parameters of the a-axis and c-axis of V-β-TCPV increased very slightly with increasing vanadium ion content. The changes in the lattice parameters of the V-β-TCPV differed from those of the V-β-TCP 5 and β-TCPV 6 . FIGURE 3 FT-IR spectra of V-β-TCPV doped with 0-1.5 mol% of vanadium ions. FIGURE 3 shows FT-IR spectra of V-β-TCPVs doped with 0-1.5 mol% vanadium ions. The bands appeared at 1100-960 and 600-570 cm -1 , which were attributed to the phosphate (PO 4 ) stretching vibrations (ν 3 , ν 1 ) and PO 4 bending vibrations (ν 4 , ν 2 ), respectively. In addition, the band at 825 cm -1 , which was attributed to the vanadate (VO 4 ) vibration, was observed in FT-IR spectra of samples containing vanadium ions. The absorption intensity of the VO 4 group increased with an increase in the amount of vanadium ions. The same tendency was observed in FT-IR spectra of HAp doped with VO 4 3ions. 9 This result indicates that V(V) ion was substituted for a P ion in the PO 4 group of β-TCP structure.
RESULTS AND DISCUSSION
Furthermore, the color of V-β-TCPV became greener with increasing vanadium ion content. Although the color change of V-β-TCPV differed from that of β-TCPV, it was similar to that of V-β-TCP. This result indicates that the prepared β-TCP was doped with both V(III) and V(V) ions. The chemical formula of V-β-TCPV calculated from the concentrations used in the preparation is shown in Table 2 . The distribution coefficients of trivalent and pentavalent vanadium were 0.333 and 0.667, respectively. Next, we investigated the in vitro cell cytotoxicity using V79 cells. Table 3 shows the in vitro cell cytotoxicity of V-β-TCPV and lists the relative numbers of colonies formed on the wells for different concentrations of the extracts and the index of cytotoxicity (IC50).
The negative control (high-density polyethylene film) did not show any cytotoxic response, as indicated by an IC50 value >100 %. On the other hand, the IC50 values of the polyurethane films containing 0.1% ZDEC and 0.25% ZDBC, i.e., positive controls A (medium cytotoxicity control) and B (low cytotoxicity control), were 6% and 72%, respectively, indicating that these materials caused a cytotoxic response. In order to assess the cytotoxicity accurately with this cytotoxicity test, the following conditions must be satisfied: (1) the colony formation ratio of the control should be more than 0.80, (2) the number of colonies for the negative control should the same as that for the control, and (3) the IC50 values of positive controls of A and B should be <7.0% and 80%, respectively. As shown in Table 3 , our cytotoxicity testes met these conditions. V-β-TCPV extracts did not inhibit colony formation up to a concentration of 50%; however, they inhibited colony formation at concentrations of 100%. In addition, the IC50 value of V-β-TCPV (1.0 mol%) was 80%, which is lower than that of the positive control of B (low cytotoxicity control). This indicates that V-β-TCPV has low cytotoxicity.
Therefore, V-β-TCPVs doped with small amounts of vanadium ions are expected to be significant new implant biomaterials.
CONCLUSION
Tricalcium phosphate doped with a small amount of both V(III) and V(V) ions (V-β-TCPV) was successfully prepared using a solid-state reaction, and its in vitro cell cytotoxicity was investigated using V79 cells. V(III) ion was substituted for a Ca ion at the Ca(5) sites located in the β-TCP crystal structure, while V(V) ion was substituted for a P ion in the PO 4 groups of the β-TCP crystal structure. The cell cytotoxicity of the V-β-TCPVs increased gradually with increasing vanadium ion content. The β-TCP doped with 1.0 mol% vanadium ions showed low toxicity.
